LYZZ Capital is a venture capital firm in Shanghai that focuses on pharmaceutical, medical, diagnostic and medical service industries. Founded 2015 in Shanghai, China, it invests in series A, series B and venture rounds. Its portfolio companies include Qpex Biopharma, Alpha Biopharma, NewMed Medical, Neurelis, and Chipscreen. As of March 2020, LYZZ Capital has made six investments. Their most recent investment was on October 22, 2018, when Qpex Biopharma raised $33M. Qpex Biopharma, Inc. is a provider of biotechnology services and is based in San Diego, California, United States. LYZZ Capital specializes in seed, early, and expansion stage venture investments.
Timeline
Funded Companies
JumpCode Genomics develops NGS solutions for the oncology, infectious disease, basic research, and consumer genomics fields.
People
Kevin Li Ph.D
Founding Managing Partner
Leo Lv
Executive
Yao Lu
General Counsel
Further reading
Documentaries, videos and podcasts
Companies
Alpha Biopharma
Chipscreen
Neurelis
NewMed Medical
Qpex Biopharma
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Henry Ogolla
Passionate about reading and writing. - 3
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 4
Amit Gehlot
Influencer + Btech from RTU, Surfing on Internet. I like to learn new things + Travel + Foody.